Genective names Qiaoni Linda Jing as Chief Executive Officer

Genective, a joint venture established between Limagrain and KWS to develop transgenic traits for corn, announced Qiaoni Linda Jing as Chief Executive Officer effective today, August 5, 2019.
 

Jing came to Genective with a decade of experience at Monsanto, recently as part of Bayer Crop Science. She held various executive roles with global responsibility in corporate affairs, R&D and supply chain at Monsanto’s headquarters, after regional commercial roles in both the U.S. and Argentina. Prior to Monsanto, Jing worked at General Motors in the U.S. and PricewaterhouseCoopers in China. Jing is an alumna of the Kellogg School of Management, Northwestern University in the U.S. and Fudan University and Soochow University in China.
 

“I am thrilled for the unique opportunity of leading Genective into a new chapter,” said Jing. “We will build and develop a top-notch research and operation team in Champaign, Illinois, which is at the heart of the largest transgenic corn market in the world. We will enhance and expand collaboration with our industry and academic partners to accelerate agriculture innovation.”
 

“With the arrival of Linda and construction of the new lab facilities in U.S., Genective will strengthen its strategic and operational capabilities to become one of the key transgenic trait providers in the market,” said Dr. Fermín Azanza, Chairman of the Board of Directors of Genective.